<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02445846</url>
  </required_header>
  <id_info>
    <org_study_id>14-0528</org_study_id>
    <nct_id>NCT02445846</nct_id>
  </id_info>
  <brief_title>Dual Rapid HIV &amp; Syphilis Tests in Zambia</brief_title>
  <official_title>Field Performance Evaluation of Dual Rapid HIV &amp; Syphilis Tests in Zambia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>World Health Organization</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to provide evidence on the performance and operational
      characteristics of commercially available dual HIV/syphilis Rapid Diagnostic Tests (RDTs) in
      Zambia for their introduction into antenatal care and other settings.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early detection and timely intervention of pregnant women infected with HIV and/or syphilis
      is critical. To improve the number of women tested and treated, the Centre for Infectious
      Disease Research in Zambia (CIDRZ) and the Ministry of Community Development, Mother and
      Health (MCDMCH) this field study will assess the effectiveness of newly developed dual HIV
      and syphilis rapid diagnostic tests (RDTs) manufactured by Chembio and Standard Diagnostics
      in Lusaka District antenatal clinics.

      The specific objectives of this field performance evaluation of the rapid diagnostics are to
      determine the antenatal clinic-based performance of dual HIV/syphilis RDTs compared to that
      of current reference standard assays, and to assess the operational characteristics and
      acceptability of these dual HIV/syphilis RDTs to patients and health care providers This
      cross-sectional study of 3,765 pregnant women will validate the performance of Chembio and
      Standard Diagnostics dual HIV and Syphilis RDTs.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2014</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>performance of dual rapid HIV/syphilis tests</measure>
    <time_frame>day 1/enrollment</time_frame>
    <description>The performance of the rapid study tests will be assessed by determining the specificity and the sensitivity when compared to reference standard assays</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>acceptability of use of dual rapid HIV/syphilis tests</measure>
    <time_frame>day 1/enrollment</time_frame>
    <description>the operational characteristics and acceptability of the tests to patients and health care providers will be measured.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3010</enrollment>
  <condition>HIV</condition>
  <condition>Syphilis</condition>
  <arm_group>
    <arm_group_label>Pregnant women</arm_group_label>
    <description>Pregnant women, regardless of HIV status, seeking antenatal care at clinics in Lusaka, Zambia</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>dual HIV/syphilis rapid diagnostics tests</intervention_name>
    <arm_group_label>Pregnant women</arm_group_label>
    <other_name>Chembio and Standard Disgnostics</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women, regardless of HIV status, seeking antenatal care at Chipata, Chawama, or
        Kamwala District Health Centres in Lusaka, Zambia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women attending their first antenatal care visit at a study clinic

          -  18 years of age or older

          -  Willing and able to provide informed consent for study participation

        Exclusion Criteria:

          -  Prior participation in the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Margaret Kasaro, MBChB, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Infectious Disease Research in Zambia</name>
      <address>
        <city>Lusaka</city>
        <country>Zambia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Zambia</country>
  </location_countries>
  <reference>
    <citation>Katepa-Bwalya M, Kankasa C, Babaniyi O, Siziya S. Effect of using HIV and infant feeding counselling cards on the quality of counselling provided to HIV positive mothers: a cluster randomized controlled trial. Int Breastfeed J. 2011 Sep 26;6:13. doi: 10.1186/1746-4358-6-13.</citation>
    <PMID>21943308</PMID>
  </reference>
  <reference>
    <citation>Kalichman SC, Pellowski J, Turner C. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect. 2011 Apr;87(3):183-90. doi: 10.1136/sti.2010.047514. Epub 2011 Feb 17. Review.</citation>
    <PMID>21330572</PMID>
  </reference>
  <reference>
    <citation>Lee MJ, Hallmark RJ, Frenkel LM, Del Priore G. Maternal syphilis and vertical perinatal transmission of human immunodeficiency virus type-1 infection. Int J Gynaecol Obstet. 1998 Dec;63(3):247-52.</citation>
    <PMID>9989893</PMID>
  </reference>
  <reference>
    <citation>Mwapasa V, Rogerson SJ, Kwiek JJ, Wilson PE, Milner D, Molyneux ME, Kamwendo DD, Tadesse E, Chaluluka E, Meshnick SR. Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi. AIDS. 2006 Sep 11;20(14):1869-77.</citation>
    <PMID>16954728</PMID>
  </reference>
  <reference>
    <citation>WHO. Progress Report 2010; Towards Universal Access: Scaling up priority HIV/AIDS interventions in the health sector; Chapter 5: Scaling Up HIV Services for Women and Children http://www.who.int/hiv/pub/2010progressreport/ch5_en.pdf. Accessed July 12, 2011.</citation>
  </reference>
  <reference>
    <citation>Watson-Jones D, Changalucha J, Gumodoka B, Weiss H, Rusizoka M, Ndeki L, Whitehouse A, Balira R, Todd J, Ngeleja D, Ross D, Buvé A, Hayes R, Mabey D. Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis. 2002 Oct 1;186(7):940-7. Epub 2002 Sep 3.</citation>
    <PMID>12232834</PMID>
  </reference>
  <reference>
    <citation>Watson-Jones D, Gumodoka B, Weiss H, Changalucha J, Todd J, Mugeye K, Buvé A, Kanga Z, Ndeki L, Rusizoka M, Ross D, Marealle J, Balira R, Mabey D, Hayes R. Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. J Infect Dis. 2002 Oct 1;186(7):948-57. Epub 2002 Sep 3.</citation>
    <PMID>12232835</PMID>
  </reference>
  <reference>
    <citation>WHO. Global prevalence and incidence of selected curable sexually transmitted infections. Overview and estimates. Geneva: http://www.who.int/hiv/pub/sti/who_hiv_aids_2001.02.pdf. Accessed April 1, 2011.</citation>
  </reference>
  <reference>
    <citation>McDermott J, Steketee R, Larsen S, Wirima J. Syphilis-associated perinatal and infant mortality in rural Malawi. Bull World Health Organ. 1993;71(6):773-80.</citation>
    <PMID>8313495</PMID>
  </reference>
  <reference>
    <citation>Di Mario S, Say L, Lincetto O. Risk factors for stillbirth in developing countries: a systematic review of the literature. Sex Transm Dis. 2007 Jul;34(7 Suppl):S11-21. Review.</citation>
    <PMID>17592385</PMID>
  </reference>
  <reference>
    <citation>Strasser S, Bitarakwate E, Gill M, Hoffman HJ, Musana O, Phiri A, Shelley KD, Sripipatana T, Ncube AT, Chintu N. Introduction of rapid syphilis testing within prevention of mother-to-child transmission of HIV programs in Uganda and Zambia: a field acceptability and feasibility study. J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):e40-6. doi: 10.1097/QAI.0b013e318267bc94.</citation>
    <PMID>22820810</PMID>
  </reference>
  <reference>
    <citation>Kettler H, White K, Hawkes S. Mapping the landscape of diagnostics for sexually transmitted infections. World Health Organization, Geneva, 2004.</citation>
  </reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2015</study_first_submitted>
  <study_first_submitted_qc>May 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2015</study_first_posted>
  <last_update_submitted>April 20, 2017</last_update_submitted>
  <last_update_submitted_qc>April 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syphilis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

